Bile emboli in the kidneys and lungs were present at autopsy in a patient who had undergone percutaneous trans-hepatic drainage for pancreatic carcinoma obstructing the common bile duct. The patient also developed hemobilia and bile peritonitis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00004836-198106000-00006 | DOI Listing |
Onco Targets Ther
December 2024
Department of Infectious Disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Background: Alectinib is a second generation of anaplastic lymphoma kinase (ALK) inhibitor that has been approved for the treatment of advanced non-small-cell lung cancer (NSCLC) with ALK rearrangements. Hepatotoxicity is the most common adverse drug reaction. However, there is currently no published report on the pathologic findings of alectinib-induced hyperbilirubinemia.
View Article and Find Full Text PDFCurr Probl Cardiol
December 2024
Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Cureus
October 2024
General Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.
Surg Obes Relat Dis
October 2024
Bariatric & Metabolic Institute, AdventHealth Tampa, Tampa, Florida. Electronic address:
Background: Symptoms of reflux after sleeve gastrectomy (SG) are common and may be refractory to medical treatment.
Objectives: To assess outcomes of conversion of SG to Roux-en-Y gastric bypass (RYGB) with concomitant repair of hiatal hernias on symptoms of reflux.
Setting: Tertiary community hospital.
Clin Pract
August 2024
HPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.
Background: Intraductal papillary neoplasms of the bile duct (IPNB) are rare precancerous lesions with implications for the development of cholangiocarcinoma (CCA). Recognizing IPNB and managing its recurrence pose challenges in clinical practice. We present two cases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!